An Interdisciplinary Innovative model of care for people with Hand OsteoArthritis (IIHOA) :a randomised controlled trial

Medical University of Vienna (Austria)0 个研究点目标入组 140 人开始时间: 2012年5月17日最近更新: 2018年12月10日

试验速览

•1. Patients meeting the American College of Rheumatology (ACR) criteria for hand OA
•2. In order not to exclude patients with hand osteoarthritis in an early stage, patients will also be eligible to participate in this study if they have bony swelling of at least one interphalangeal (IP) joint of the 2nd to 5th finger and/ or pain or bony swelling of at least one carpometacarpal (CMC) 1 joint
•3. To have a potential for improvement (and motivation for adherence to the treatment), eligible patients have to be above or equal to an 11- point Likert scale of hand pain of at least 3 at two time points

•1. Patients with evidence of rheumatoid arthritis or any rheumatic disease other than OA
•2. Furthermore, persons with elevated C-reactive protein levels (>0.5 mg/dl) as a sign of active inflammation at the test visit and/ or with soft tissue swelling of any of the finger joints on either hand
•3. Patients who have received steroid injections within the last four weeks
•4. Patients who have undergone hand surgery within the last year
•5. Patients who plan to receive steroid injections or hand surgery during the study period

发起方

Medical University of Vienna (Austria)